Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Meda has acquired three over-the-counter (OTC) consumer products in the US from GlaxoSmithKline (GSK).
Subscribe to our email newsletter
Meda and GSK are also pursuing further discussions on additional OTC acquisitions in the US market.
Meda is an international specialty pharma company engaged in marketing and product development in late clinical phase.
Meda claims that its products are sold in 120 countries worldwide and the company is represented by its own organisations in 50 countries.
Meda CEO Anders Lonner said that these well known consumer brands strengthen our OTC business in the US.